How do you take vitamin B12?

How injectable B12 is supplied
ProductStrengthSupplied
US cyanocobalamin label11000 mcg per mL10 mL multiple dose vial
US hydroxocobalamin label41,000 mcg/mL30 mL multiple dose vial
UK hydroxocobalamin SmPC21 mg/mLGlass ampoules, 5 per pack

For pernicious anemia, the US cyanocobalamin label gives 100 mcg daily for 6 or 7 days by intramuscular or deep subcutaneous injection, then alternate-day doses and doses every 3 to 4 days, then 100 mcg monthly for life; for anaemias without neurological involvement, the UK hydroxocobalamin SmPC gives 250 to 1000 micrograms intramuscularly on alternate days for one or two weeks, then 250 micrograms weekly until the blood count is normal, then 1000 micrograms every two to three months; by mouth, a trial of 38 patients gave 2 mg daily for 120 days, and the US label calls oral absorption too undependable to rely on in pernicious anemia.123

How injectable B12 is supplied

The table is set at the top of the page

Searches of DailyMed, the emc and ClinicalTrials.gov found no B12 label for a powder or a pen; the only reconstituted product found was Cyanokit, a 5 g intravenous hydroxocobalamin product for cyanide poisoning.5

What the labels give for dose and schedule

For pernicious anemia, the US cyanocobalamin label gives 100 mcg daily for 6 or 7 days by intramuscular or deep subcutaneous injection; if there is clinical improvement and a reticulocyte response, the same amount on alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks, then 100 mcg monthly for life.1 For pernicious and other macrocytic anaemias without neurological involvement, the UK hydroxocobalamin SmPC gives 250 to 1000 micrograms intramuscularly on alternate days for one or two weeks, then 250 micrograms weekly until the blood count is normal, then 1000 micrograms every two to three months.2 With neurological involvement, the SmPC gives 1000 micrograms on alternate days as long as improvement is occurring.2 The US hydroxocobalamin label gives thirty mcg daily for 5 to 10 days, then 100 to 200 mcg monthly, intramuscularly only, and says considerably higher doses may be indicated in critical illness, neurologic disease, an infectious disease or hyperthyroidism.4 The US cyanocobalamin label says to avoid the intravenous route, since intravenous use "will result in almost all of the vitamin being lost in the urine"; the saved labels give no injection-site rotation instruction, and searches found no human trial of a subcutaneous B12 dose.1

What trials used by mouth and by injection

TrialDose and schedulePeopleLength
Kuzminski 19983Oral 2 mg daily, or intramuscular 1 mg on days 1, 3, 7, 10, 14, 21, 30, 60 and 9038 newly diagnosed cobalamin-deficient patients120 days (oral), day 90 (intramuscular)
Eussen 20056Oral cyanocobalamin daily, 2.5, 100, 250, 500 or 1000 mug120 older people with mild deficiency16 weeks
OB127Intramuscular on alternate days in weeks 1–2, 1 mg/week in weeks 3–8 and 1 mg/month in weeks 9–52; oral 1 mg/day in weeks 1–8 and 1 mg/week in weeks 9–52283 patients aged 65 or older with B12 deficiency (140 oral, 143 intramuscular)52 weeks
Bolaman 2003, Turkey81000-microg oral or intramuscular once daily for 10 days, weekly for 4 weeks, then monthlyMegaloblastic anemia from cobalamin deficiency; sixty completed (26 oral, 34 intramuscular)90 days

Kuzminski reported that correction of hematologic and neurologic abnormalities was prompt and indistinguishable between the groups (18 evaluable patients oral, 15 parenteral); serum cobalamin was significantly higher and methylmalonic acid lower in the oral group at 4 months, and the authors wrote that 2 mg of cyanocobalamin orally on a daily basis was as effective as 1 mg intramuscularly on a monthly basis and may be superior.3 OB12 concluded oral was no less effective than intramuscular at 8 weeks; at week 52, 73.6% of the oral arm and 80.4% of the intramuscular arm had normal B12 levels; 83.4% of patients preferred the oral route.7

Daily amounts health bodies give

The Linus Pauling Institute gives the adult RDA as 2.4 mcg a day, 2.6 in pregnancy and 2.8 while breastfeeding.9 For pernicious anemia, it says injections are generally required, with high-dose oral B12 another possible option: 1,000 mcg (1 mg) a day by mouth is put at about 10 mcg a day absorbed by passive diffusion, though it adds that the effect of oral B12 varies among patients and that the trials comparing the two are considered to be of low quality.9

Storage

The US cyanocobalamin label states storage at 20 to 25 C, with protection from light and inspection before use.1 The UK SmPC gives a 2-year shelf life at or below 25 C.2 Searches found no stability data for diluted or mixed B12.

Frequently asked questions

Does metformin lower vitamin B12?

In the HOME trial (de Jager 2010) of 390 insulin-treated people aged 30-80 with type 2 diabetes, 850 mg of metformin three times a day was associated with a 19% decrease in vitamin B12 concentration compared with placebo, over 4.3 years of follow-up.10

What safety warnings does the cyanocobalamin label give?

It warns of anaphylactic shock and death after parenteral B12, and of hypokalemia and sudden death in severe megaloblastic anemia treated intensely.1

References

  1. Henry Schein / Vitruvias (DailyMed). Cyanocobalamin Injection USP 1000 mcg/mL. 2026. dailymed.nlm.nih.gov
  2. emc (UK SmPC). Hydroxocobalamin 1mg/ml Solution for Injection - Summary of Product Characteristics (SmPC) - print friendly - (emc). medicines.org.uk
  3. PubMed. Effective treatment of cobalamin deficiency with oral cobalamin. 1998. pubmed.ncbi.nlm.nih.gov
  4. DailyMed. HYDROXOCOBALAMIN INJECTION USP Rx Only. 2017. dailymed.nlm.nih.gov
  5. DailyMed. These highlights do not include all the information needed to use CYANOKIT safely and effectively. See full prescribing information for CYANOKIT. CYANOKIT ® (hydroxocobalamin for injection) for intravenous infusion Initial U.S. Approval: 1975. 2023. dailymed.nlm.nih.gov
  6. PubMed. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. 2005. pubmed.ncbi.nlm.nih.gov
  7. PMC. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). 2020. pmc.ncbi.nlm.nih.gov
  8. PubMed. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. 2003. pubmed.ncbi.nlm.nih.gov
  9. Linus Pauling Institute. Vitamin B12 | Linus Pauling Institute. lpi.oregonstate.edu
  10. PMC (BMJ). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. 2010. pmc.ncbi.nlm.nih.gov